李小加百威亚太(01876.HK)搁置上市为个别个案正研究缩短散户需提前投入资金措施
港交所(00388.HK)行政总裁李小加表示,百威英博母公司决定放弃分拆百威亚太(01876.HK)上市计划是个别个案,不代表香港对上市公司的吸引力减少。他指此举反映本港的上市机制完善,发行人及投资者皆有自由在上市前作出决定。
不过他亦承认,在目前T+5的上市制度下,散户需要提前投入资金,并面对上市公司的不确定性。港交所目前正在研究缩短散户需要提前投入资金的措施,与机构投资者看齐,不过仍需要考虑平衡上市公司及散户之间的利益。
至於有指阿里巴巴於本港第二上市集资额自200亿美元下调至100亿美元,他指不评论个别公司没有正式公布的消息。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.